S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known if carboplatin is more effective with or without liposomal doxorubicin in treating
recurrent ovarian epithelial or primary peritoneal cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of carboplatin with or
without liposomal doxorubicin in treating patients who have recurrent ovarian epithelial or
primary peritoneal cancer.